| Literature DB >> 31623349 |
Yi-Hung Liao1, Yi-Chen Chao2, Brenton Yim-Quan Sim2, Hui-Mei Lin3, Mu-Tsung Chen4, Chung-Yu Chen5.
Abstract
Rhodiola crenulata (R) and Cordyceps sinensis (C) are commonly used herbs that promote health in traditional Chinese medicine. These two herbs have also been shown to exhibit anti-inflammation and antioxidant functions. Regular endurance training reveals potent endurance capacity, body composition improvement, and metabolic-related biomarker benefits. However, it is not known whether the combination of Rhodiola crenulata and Cordyceps sinensis (RC) supplementation during endurance training provides additive health benefits. The purpose of this study was to investigate the effects of 8-week endurance training plus RC supplementation on body composition, oxidative stress, and metabolic biomarkers in young sedentary adults.Entities:
Keywords: Chinese herbs; body fat mass; maximal oxygen consumption; skeletal muscle
Mesh:
Substances:
Year: 2019 PMID: 31623349 PMCID: PMC6835767 DOI: 10.3390/nu11102357
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow chart of the study.
Figure 2Chromatographic fingerprints of the Rhodiola (A) and Cordyceps (B) supplement by high-performance liquid chromatography (HPLC) analysis.
Eight week training program.
| Week | Frequency (times/week) | Intensity (%Wmax) | Duration (min) |
|---|---|---|---|
| Week 1 | 3 | 60 | 30/40/50 |
| Week 2 | 3 | 60 | 60 |
| Week 3 | 3 | 65 | 30/40/50 |
| Week 4 | 3 | 65 | 60 |
| Week 5 | 3 | 70 | 30/40/50 |
| Week 6 | 3 | 70 | 60 |
| Week 7 | 3 | 75 | 30/40/50 |
| Week 8 | 3 | 75 | 60 |
Baseline characteristics of the participants.
| Baseline Characteristics | PLA | RC |
|---|---|---|
| Gender (male: female) | 4 : 3 | 4 : 3 |
| Age (years) | 21.4 ± 0.4 | 21.7 ± 0.4 |
| Body weight (kg) | 69.7 ± 5.0 | 67.6 ± 4.8 |
| Height (cm) | 168.0 ± 2.3 | 167.7 ± 4.0 |
| VO2max (ml/kg/min) | 36.9 ± 2.2 | 35.4 ± 1.1 |
Values are expressed as the mean ± S.E.M. VO2max: maximum oxygen uptake. PLA: placebo; RC: Rhodiola crenulata and Cordyceps sinensis supplementation.
Body composition assessment.
| Body Composition | PLA | RC | ||
|---|---|---|---|---|
| Assessment | Pre | Post | Pre | Post |
| Body weight (kg) | 69.7 ± 5.0 | 69.2 ± 5.4 | 67.6 ± 4.8 | 65.7 ± 4.8 † |
| BMI (kg/m2) | 24.6 ± 1.4 | 24.5 ± 1.5 | 23.9 ± 0.9 | 23.0 ± 2.3 † |
| Body fat (%) | 26.6 ± 2.8 | 26.0 ± 2.8 | 27.3 ± 2.8 | 25.5 ± 2.7 † |
| Skeletal muscle tissue | ||||
| Upper limbs (kg) | 5.4 ± 0.4 | 5.4 ± 0.4 | 5.3 ± 0.7 | 5.2 ± 0.7 |
| Lower limbs (kg) | 16.2 ± 1.0 | 16.3 ± 1.0 | 15.0 ± 1.6 | 15.3 ± 1.6 † |
| Trunk (kg) | 22.6 ± 1.2 | 22.6 ± 1.3 | 22.2 ± 2.3 | 21.9 ± 2.2 |
| Adipose tissue | ||||
| Upper limbs (kg) | 2.5 ± 0.5 | 2.4 ± 0.6 | 2.3 ± 0.3 | 2.0 ± 0.3 † |
| Lower limbs (kg) | 5.8 ± 0.8 | 5.6 ± 0.8 | 5.3 ± 0.4 | 5.0 ± 0.4 |
| Trunk (kg) | 9.5 ± 1.6 | 9.4 ± 1.7 | 9.3 ± 0.8 | 8.3 ± 0.9 † |
Values are expressed as the mean ± S.E.M. BMI: body mass index, † denotes the significant difference from the Pre value (p < 0.05). PLA: placebo; RC: Rhodiola crenulata and Cordyceps sinensis supplementation.
Figure 3Changes in the body composition between the placebo and RC groups after eight weeks of intervention. The RC group showed lower body weight, BMI (A) and upper limb adipose tissue (B) after intervention. Compared to the placebo group, the RC group showed higher muscle mass in the lower limb (C) after treatment. BW: Body weight; BMI: Body mass index; % BF: Percentage of fat mass. Open blue circle: PLA group; Open red circle: RC group (Figure 3A). Blue open triangle/diamond: Left/right arm and leg in PLA; Blue solid circle: Upper limb/Lower limb (sum of left + right arm/leg in PLA). Red open triangle/diamond: Left/right arm and leg in RC; Red solid circle: Upper limb/Lower limb (sum of left + right arm/leg in RC) (Figure 3B,C). * denotes the significant difference between the placebo and RC groups (p < 0.05). Values are expressed as the mean ± S.E.M.
The changes in VO2max and metabolic parameters and oxidative stress markers after eight weeks of intervention.
| Metabolic and Oxidative Stress | PLA | RC | ||
|---|---|---|---|---|
| Measurement | Pre | Post | Pre | Post |
| VO2max (mL/kg/min) | 36.9 ± 2.2 | 40.2 ± 3.0† | 35.4 ± 1.1 | 39.5 ± 1.7† |
| Insulin (µIU/mL) | 13.2 ± 1.7 | 7.9 ± 0.8 † | 13.8 ± 2.0 | 8.7 ± 0.9 † |
| McAuley Index | 7.5 ± 0.5 | 9.2 ± 0.8 | 7.6 ± 0.7 | 8.8 ± 0.6 |
| HOMA-IR | 2.6 ± 0.4 | 1.5 ± 0.2 † | 2.7 ± 0.4 | 1.6 ± 0.2 † |
| SBP (mmHg) | 112.9 ± 3.2 | 110.0 ± 4.9 | 119.7 ± 2.9 | 110.4 ± 5.5 |
| DBP (mmHg) | 70.4 ± 2.1 | 67.1 ± 3.0 | 69.0 ± 2.2 | 68.1 ± 3.6 |
| MAP (mmHg) | 84. 6 ± 1.9 | 81.4 ± 3.0 | 85.9 ± 1.8 | 82.2 ± 3.6 |
| CHOL (mg/dL) | 179.8 ± 10.6 | 177.7 ± 10.5 | 180.4 ± 7.6 | 187.8 ± 10.0 |
| TG (mg/dL) | 78.1 ± 15.0 | 67.7 ± 17.2 | 69.5 ± 9.1 | 67.2 ± 15.7 |
| HDL-C (mg/dL) | 55.3 ± 6.7 | 56.8 ± 6.5 | 55.5 ± 3.7 | 59.9 ± 4.9 |
| LDL-C (mg/dL) | 106.8 ± 8.6 | 101.1 ± 11.8 | 108.0 ± 4.9 | 105.7 ± 6.9 |
| LDL/HDL | 2.1 ± 0.3 | 2.0 ± 0.4 | 1.9 ± 0.1 | 1.8 ± 0.2 |
| CHOL/HDL | 3.4 ± 0.4 | 3.4 ± 0.5 | 3.3 ± 0.2 | 3.2 ± 0.2 |
| TBARS (µM) | 4.1 ± 0.4 | 4.2 ± 0.9 | 5.0 ± 0.5 | 4.6 ± 0.4 |
| TAC (mM) | 4.9 ± 0.5 | 4.8 ± 0.4 | 4.3 ± 0.5 | 4.3 ± 0.4 |
Values are expressed as the mean ± S.E.M. VO2max: Maximum oxygen uptake, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, MAP: Mean arterial pressure, CHOL: Cholesterol, TG: Triglyceride, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol, LDL/HDL: LDL-C to HDL-C ratio, CHOL/HDL: Cholesterol to HDL-C ratio, TBARS: Thiobarbituric acid reactive substances, TAC: Total antioxidant capacity. † denotes the significant difference from Pre value (p < 0.05). PLA: placebo; RC: Rhodiola crenulata and Cordyceps sinensis supplementation.
Figure 4Changes in the metabolic parameters between the placebo and RC groups following eight weeks of intervention. No difference in the glucose metabolism (A), blood pressure (B), and lipid profile (C) changes in both groups after treatment. Blue solid circle: placebo (PLA); Red solid circle: RC supplementation (RC). SBP: Systolic blood pressure, DBP: Diastolic blood pressure. MAP: Mean arterial pressure. CHOL: Cholesterol, TG: Triglyceride, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol, LDL/HDL: LDL-C to HDL-C ratio. Values are expressed as the mean ± S.E.M.
Figure 5Changes in the oxidative and anti-oxidative biomarkers between the placebo and RC groups after eight-week intervention. No significant difference in TBARS and TAC levels between groups after intervention. Blue solid circle: placebo (PLA); Red solid circle: RC supplementation (RC). TBARS: Thiobarbituric acid reactive substances, TAC: Total antioxidant capacity. Values are expressed as Mean ± S.E.M.